EMA — authorised 26 August 2020
- Marketing authorisation holder: Hansa Biopharma AB
- Status: approved
🇪🇺 Ides in European Union
EMA authorised Ides on 26 August 2020
Marketing authorisation
Ides in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in European Union
Frequently asked questions
Is Ides approved in European Union?
Yes. EMA authorised it on 26 August 2020.
Who is the marketing authorisation holder for Ides in European Union?
Hansa Biopharma AB holds the EU marketing authorisation.